Cardiovascular protection: Some GLP-1 medications have been shown to reduce the risk of major cardiovascular events such as heart attack, stroke, and cardiovascular death in people with type 2 diabetes, particularly those with existing cardiovascular disease or multiple risk factors
It helps produce adenosine triphosphate (ATP), the primary energy source for cells
However, since no measurements of splanchnic hemodynamic changes after more long-term exposure to GIP receptor antagonism have been conducted, in either animal models or humans, the therapeutic implications of this effect are uncertain
Klow Stack peptide is a branded term used for multi-peptide stack formulations rather than a single standardized compound
The CJC-1295 (a GHRH) increases the number of pituitary cells releasing GH, while Ipamorelin (a GHRP) increases the amplitude of the pulse from those cells